HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Kawamura Selected Research

flumioxazin

1/2021Different effects of an N-phenylimide herbicide on heme biosynthesis between human and rat erythroid cells.
4/2014Dermal developmental toxicity of N-phenylimide herbicides in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoshi Kawamura Research Topics

Disease

8Neoplasms (Cancer)
10/2019 - 03/2009
4Hepatocellular Carcinoma (Hepatoma)
08/2021 - 01/2017
4Ventricular Heart Septal Defects (Ventricular Septal Defect)
01/2021 - 12/2013
3Carcinogenesis
01/2022 - 11/2018
3Hypertrophy
01/2017 - 03/2009
2Fibrosis (Cirrhosis)
01/2022 - 10/2016
2Anemia
01/2021 - 02/2016
2Ascites
10/2019 - 10/2016
1Non-alcoholic Fatty Liver Disease
01/2022
1Carcinoma (Carcinomatosis)
01/2021
1Acute Erythroblastic Leukemia (Erythroleukemia)
01/2021
1Fever (Fevers)
11/2020
1Cholangitis
11/2020
1Obesity
11/2018
1Hyperplasia
01/2017
1Adenoma (Adenomas)
01/2017
1Weight Loss (Weight Reduction)
10/2016
1Hyponatremia
10/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2016
1Cardiomegaly (Heart Hypertrophy)
02/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2013
1Adenocarcinoma
10/2012
1Paresthesia (Dysesthesia)
01/2012
1Pruritus (Itching)
01/2012
1Tremor (Tremors)
01/2012
1Alzheimer Disease (Alzheimer's Disease)
09/2011
1Cognitive Dysfunction
09/2011
1Borderline Personality Disorder (Personality Disorders, Borderline)
01/2011
1Major Depressive Disorder (Major Depressive Disorders)
01/2011
1Feminization
03/2010
1Body Weight (Weight, Body)
03/2010
1Conduct Disorder (Conduct Disorders)
12/2008
1Migraine Disorders (Migraine)
06/2008
1Hyperprolactinemia
02/2007
1Psychotic Disorders (Schizoaffective Disorder)
02/2007

Drug/Important Bio-Agent (IBA)

4Phenobarbital (Luminal)FDA Link
01/2021 - 03/2009
4HerbicidesIBA
01/2021 - 12/2013
4Constitutive Androstane ReceptorIBA
01/2017 - 04/2009
4Pyrethrins (Pyrethroids)FDA Link
01/2017 - 03/2009
3(2,3,5,6- tetrafluoro- 4- methoxymethylphenyl)methyl- 2,2- dimethyl- 3- (1- propenyl)cyclopropanecarboxylateIBA
01/2017 - 03/2009
2flumioxazinIBA
01/2021 - 04/2014
2Protoporphyrinogen Oxidase (Protox)IBA
01/2021 - 02/2016
2ChlorophyllIBA
01/2021 - 02/2016
2Heme (Haem)IBA
01/2021 - 02/2016
2Sorafenib (BAY 43-9006)FDA Link
01/2017 - 01/2017
2momfluorothrinIBA
01/2017 - 01/2017
2Biomarkers (Surrogate Marker)IBA
08/2013 - 10/2012
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
04/2009 - 03/2009
2Oral ContraceptivesIBA
06/2008 - 02/2007
1SREBP cleavage-activating proteinIBA
01/2022
1Sterol Regulatory Element Binding ProteinsIBA
01/2022
1Pharmaceutical PreparationsIBA
08/2021
1CateninsIBA
08/2021
1Biological ProductsIBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
11/2020
1PlasticsIBA
10/2019
1Concanavalin AIBA
10/2019
1Glucose (Dextrose)FDA LinkGeneric
11/2018
1Glutamine (L-Glutamine)FDA Link
11/2018
1LipidsIBA
11/2018
1Fatty Acids (Saturated Fatty Acids)IBA
11/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1Permethrin (Ambush)FDA LinkGeneric
01/2017
1BilirubinIBA
10/2016
1TolvaptanFDA Link
10/2016
1Urea (Carbamide)FDA LinkGeneric
10/2016
1DiureticsIBA
10/2016
1NitrogenIBA
10/2016
1Blood Proteins (Serum Proteins)IBA
02/2016
1S 23121IBA
04/2014
1Proteins (Proteins, Gene)FDA Link
08/2013
1MicroRNAs (MicroRNA)IBA
10/2012
1Brain-Derived Neurotrophic Factor (BDNF)IBA
09/2011
1Interleukin-6 (Interleukin 6)IBA
01/2011
1Cytochrome P-450 CYP11B2 (CYP11B2)IBA
01/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2011
1Androgen Antagonists (Antiandrogens)IBA
03/2010
1Cyproterone AcetateIBA
03/2010
1Insulin (Novolin)FDA Link
12/2008

Therapy/Procedure

1Length of Stay
11/2020
1Withholding Treatment
01/2017
1Cutaneous Administration
04/2014